Chow CR - Search Results

1

Estimation of Absolute and Relative Body Fat Content Using Noninvasive Surrogates: Can DXA Be Bypassed?

Greenblatt DJ, Bruno CD, Harmatz JS, Dawson-Hughes B, Zhang Q, Li C, Chow CR. Greenblatt DJ, et al. Among authors: chow cr. J Clin Pharmacol. 2023 Nov;63 Suppl 2(Suppl 2):S35-S47. doi: 10.1002/jcph.2306. J Clin Pharmacol. 2023. PMID: 37942909 Free PMC article.

2

Impaired Rivaroxaban Clearance in Mild Renal Insufficiency With Verapamil Coadministration: Potential Implications for Bleeding Risk and Dose Selection.

Greenblatt DJ, Patel M, Harmatz JS, Nicholson WT, Rubino CM, Chow CR. Greenblatt DJ, et al. Among authors: chow cr. J Clin Pharmacol. 2018 Apr;58(4):533-540. doi: 10.1002/jcph.1040. Epub 2017 Nov 30. J Clin Pharmacol. 2018. PMID: 29194698 Clinical Trial.

3

Vortioxetine Disposition in Obesity: Potential Implications for Patient Safety.

Greenblatt DJ, Harmatz JS, Chow CR. Greenblatt DJ, et al. Among authors: chow cr. J Clin Psychopharmacol. 2018 Jun;38(3):172-179. doi: 10.1097/JCP.0000000000000861. J Clin Psychopharmacol. 2018. PMID: 29596146

4

Persistence of a Posaconazole-Mediated Drug-Drug Interaction With Ranolazine After Cessation of Posaconazole Administration: Impact of Obesity and Implications for Patient Safety.

Chow CR, Harmatz JS, Ryan MJ, Greenblatt DJ. Chow CR, et al. J Clin Pharmacol. 2018 Nov;58(11):1436-1442. doi: 10.1002/jcph.1257. Epub 2018 May 11. J Clin Pharmacol. 2018. PMID: 29749631

5

Sustained Impairment of Lurasidone Clearance After Discontinuation of Posaconazole: Impact of Obesity, and Implications for Patient Safety.

Greenblatt DJ, Harmatz JS, Ryan MJ, Chow CR. Greenblatt DJ, et al. Among authors: chow cr. J Clin Psychopharmacol. 2018 Aug;38(4):289-295. doi: 10.1097/JCP.0000000000000892. J Clin Psychopharmacol. 2018. PMID: 29851709 Clinical Trial.

6

HLA associations with infliximab-induced liver injury.

Bruno CD, Fremd B, Church RJ, Daly AK, Aithal GP, Björnsson ES, Larrey D, Watkins PB, Chow CR. Bruno CD, et al. Among authors: chow cr. Pharmacogenomics J. 2020 Oct;20(5):681-686. doi: 10.1038/s41397-020-0159-0. Epub 2020 Feb 6. Pharmacogenomics J. 2020. PMID: 32024945

7

Germline Genetic Risk Variants for Progressive Multifocal Leukoencephalopathy.

Eis PS, Bruno CD, Richmond TA, Koralnik IJ, Hanson BA, Major EO, Chow CR, Hendel-Chavez H, Stankoff B, Gasnault J, Taoufik Y, Hatchwell E. Eis PS, et al. Among authors: chow cr. Front Neurol. 2020 Mar 17;11:186. doi: 10.3389/fneur.2020.00186. eCollection 2020. Front Neurol. 2020. PMID: 32256442 Free PMC article.

8

Effect of lipophilicity on drug distribution and elimination: Influence of obesity.

Bruno CD, Harmatz JS, Duan SX, Zhang Q, Chow CR, Greenblatt DJ. Bruno CD, et al. Among authors: chow cr. Br J Clin Pharmacol. 2021 Aug;87(8):3197-3205. doi: 10.1111/bcp.14735. Epub 2021 Feb 16. Br J Clin Pharmacol. 2021. PMID: 33450083 Free article.

9

Brexpiprazole Pharmacokinetics in CYP2D6 Poor Metabolizers: Using Physiologically Based Pharmacokinetic Modeling to Optimize Time to Effective Concentrations.

Elmokadem A, Bruno CD, Housand C, Jordie EB, Chow CR, Lesko LJ, Greenblatt DJ. Elmokadem A, et al. Among authors: chow cr. J Clin Pharmacol. 2022 Jan;62(1):66-75. doi: 10.1002/jcph.1946. Epub 2021 Aug 26. J Clin Pharmacol. 2022. PMID: 34328221

10

Impact of Obesity on Brexpiprazole Pharmacokinetics: Proposal for Improved Initiation of Treatment.

Bruno CD, Elmokadem A, Housand C, Jordie EB, Chow CR, Laughren TP, Greenblatt DJ. Bruno CD, et al. Among authors: chow cr. J Clin Pharmacol. 2022 Jan;62(1):55-65. doi: 10.1002/jcph.1947. Epub 2021 Aug 26. J Clin Pharmacol. 2022. PMID: 34339048

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters